Op-ed
All op-eds
Analyses, op-eds and perspectives on access to treatment in the MENA region.
The MENA H Coalition calls for sustained investments in the fight against tuberculosis in the MENA region
Joint press release FOR IMMEDIATE RELEASE MENA-H coalition urges urgent action to combat tuberculosis in the region, with emphasis on innovation and universal health coverage 2025, March 24 – On World Tuberculosis Day, the MENA-H Coalition issues an urgent call to intensify efforts to eliminate tuberculosis (TB) in the Middle East and North Africa (MENA) […]
Read →
“Not in Our Name” – African HIV Treatment Advocates React to Gilead’s Voluntary Licensing Agreement on Lenacapavir
Press Statement – 4 October 2024 Today’s announcement by Gilead that six generic manufacturers have been awarded voluntary licenses for the production of lenacapavir—a groundbreaking, twice-yearly injectable for HIV prevention and potential treatment—raises significant concerns despite the inclusion of most African countries in the license territory. Exclusionary Practices: While most countries of the continent are part of […]
Read →
Why the World Can’t Trust Pharmaceutical Companies to Ensure Global Access to Essential Medicines
Source : ITPC Global ITPC Global’s reaction to Gilead’s voluntary licence on lenacapravir: Gilead’s announcement of their voluntary license for lenacapavir—a groundbreaking, long-acting HIV prevention method—highlights why we cannot rely on pharmaceutical companies to deliver genuine global access strategies for the medicines, vaccines and diagnostics that the world needs. Lenacapavir (LEN), a twice-yearly injection, has […]
Read →